TNDM 241220 35.00P (TNDM241220P35000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

TNDM241220P35000

Watchlist

4.40
-0.10-2.22%

15min DelayClose Nov 27 16:00 ET

4.60High4.40Low

Intraday

5D
Daily

News

Leerink Partners Keeps Their Buy Rating on Tandem Diabetes Care (TNDM)
TipRanks04:26 ET · Ratings
Express News | Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $58 From $59
ReutersNov 25 07:23 ET
This Insider Has Just Sold Shares In Tandem Diabetes Care
Simply Wall StNov 25 05:01 ET
Tandem Diabetes Care Announces Upcoming Conference Presentations
Tandem Diabetes Care Nov 21 00:00 ET
Morgan Stanley Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $45
Moomoo NewsNov 11 08:31 ET · Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT), Pharvaris (PHVS) and Tandem Diabetes Care (TNDM)
TipRanksNov 11 08:21 ET · Ratings

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?